P01.14: Atypical reduction of ductus venosus systolic forward flow in three fetuses with severe tricuspid regurgitation

2004 ◽  
Vol 24 (3) ◽  
pp. 272-272
Author(s):  
J. Smrcek ◽  
M. Krapp ◽  
R. Axt-Fliedner ◽  
K. Diedrich ◽  
U. Gembruch
Keyword(s):  
Tricuspid Regurgitation ◽  
Ductus Venosus ◽  
Severe Tricuspid Regurgitation ◽  
Forward Flow

scholarly journals Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation

2019 ◽  
Vol 74 (24) ◽  
pp. 2998-3008 ◽  
Author(s):  
Maurizio Taramasso ◽  
Giovanni Benfari ◽  
Pieter van der Bijl ◽  
Hannes Alessandrini ◽  
Adrian Attinger-Toller ◽  
...  
Keyword(s):  
Medical Treatment ◽  
Tricuspid Regurgitation ◽  
Severe Tricuspid Regurgitation

Isolated Severe Tricuspid Regurgitation

2021 ◽  
Vol 77 (18) ◽  
pp. 2350-2351
Author(s):  
Jinmiao Chen ◽  
Minzhi Lv ◽  
Kui Hu ◽  
Yang Ming ◽  
Lai Wei
Keyword(s):  
Tricuspid Regurgitation ◽  
Severe Tricuspid Regurgitation

scholarly journals Severe tricuspid regurgitation 14 years after diagnosis of “transient neonatal tricuspid regurgitation”

Heart ◽  
2001 ◽  
Vol 86 (1) ◽  
pp. 88-90
Author(s):  
D Boshoff ◽  
L Mertens ◽  
M Gewillig
Keyword(s):  
Tricuspid Regurgitation ◽  
Neonatal Period ◽  
Clinical Course ◽  
Subsequent Evolution ◽  
Severe Tricuspid Regurgitation ◽  
Echocardiographic Examination ◽  
Long Term Follow Up ◽  
Transient Tricuspid Regurgitation

A 14 year old girl presented with severe tricuspid regurgitation after she was diagnosed with “transient tricuspid regurgitation of the newborn”. In the neonatal period she had presented with severe tricuspid regurgitation without an obvious underlying anatomical cause. This spontaneously regressed during the first months of life. She was dismissed from follow up at the age of 5 years after complete normalisation of the clinical and echocardiographic examination. The subsequent evolution and management of the patient, as well as the possible pathogenesis responsible for the unusual clinical course, is discussed. This case stresses the importance of long term follow up of patients with transient tricuspid regurgitation.

scholarly journals CONTEMPORARY NATURAL HISTORY OF ISOLATED SEVERE TRICUSPID REGURGITATION BY ETIOLOGY AND MANAGEMENT

2021 ◽  
Vol 77 (18) ◽  
pp. 1692
Author(s):  
Tom Kai Ming Wang ◽  
Kevser Akyuz ◽  
Jason Kirincich ◽  
Alejandro Duran Crane ◽  
Samantha Xu ◽  
...  
Keyword(s):  
Natural History ◽  
Tricuspid Regurgitation ◽  
Severe Tricuspid Regurgitation ◽  
History Of

scholarly journals Heterotopic caval valve implantation for the management of severe tricuspid regurgitation: a case series

2020 ◽  
Author(s):  
Aidan Sharkey ◽  
Ronny Munoz Acuna ◽  
Kiran Belani ◽  
Ravi K Sharma ◽  
Omar Chaudhary ◽  
...  
Keyword(s):  
Medical Therapy ◽  
Tricuspid Regurgitation ◽  
Surgical Intervention ◽  
Symptom Relief ◽  
Vena Cava ◽  
Case Series ◽  
High Morbidity ◽  
Severe Tricuspid Regurgitation ◽  
Maximal Medical Therapy ◽  
Valve Implantation

Abstract Background Severe tricuspid regurgitation (TR) is a complex condition that can be difficult to treat medically, and often surgical intervention is prohibited due to the high morbidity and mortality associated with this intervention. In patients who have failed maximal medical therapy and have progressive symptoms related to their severe TR, heterotopic caval valve implantation (CAVI) offers potential for symptom relief for these patients. Case summary We present two cases of patients with severe TR with symptoms of heart failure that were refractory to medical therapy. Due to extensive comorbidities in these patient’s surgical intervention was deemed unsuitable and the decision was made to proceed with heterotopic CAVI in order to try and control their symptoms. Both patients successfully underwent the procedure and had an Edwards SAPIEN 3 valve (Edwards Lifesciences, Irvine, CA, USA) implanted in the inferior vena cava/right atrium junction. In both patients, there was improvement in the postoperative haemodynamics as measured by invasive and non-invasive methods. Successful discharge was achieved in both patients with improvement in their symptoms. Discussion Selective use of heterotopic CAVI to treat symptomatic severe TR that is refractory to medical therapy may be a viable option to improve symptoms in those patients that are unsuitable for surgical intervention.

Sign in / Sign up

Export Citation Format

Share Document